Figures & data
Table 1 Annual rates of detection per patient of benzodiazepines and related compounds (BDRC), including their metabolites (compounds with at least 40 detections).
Table 1 The synthetic cathinones detected in 66 patients over a 5 year period.
Table 1 Annual numbers of NPS detections per patient by category.
Table 1 Mushroom ingestion calls to the Danish Poisons information Centre, specifications on ingestions of amatoxin mushrooms, and the use of silibinin.
Table 1 Summary of children with chronic vitamin D overdose.
Table 1 Blood results during presentation in an elderly male who accidentally ingested Wetter 600 (nonoxynol-9 at 600 g/L).
Table 1 Timeline of events, onset of symptoms, findings, and treatment in two patients with delirium after accidental ingestion of Datura stramonium.
Table 1 Data collected using the Euro-DEN Plus minimum dataset from sentinel centres in 2021 and 2022. (EU4Monitoring Drugs (EU4MD) and Instrument for Pre-accession Assistance (IPA) 7 project).
Table 1 The use of multiplex kit for snake bites in Asia.
Table 1 Endoscopic gastric decontamination (EGD) after gastric lavage (GL) in patients presenting with severe or life-threatening drug poisoning.
Table 1 Clinical details of patients with intravascular administration of biguanide wound cleansing solutions.
Table 1 Sensitivity, specificity, and positive likelihood ratio of clinical findings associated with analytically confirmed opioid exposure in emergency department illicit drug presentations with hypoxaemia.
Table 1 Annual SCRA detection rates for compounds with at least 20 individual detections in the IONA study.
Table 1 Data on ketamine abuse in the Netherlands.
Table 1 Summary of the addictions, mental and physical health treatment received for patients admitted to the Addiction Clinical Care Suite (ACCS) (N = 84).
Table 1 Use of fomepizole by listed toxicant reported to America’s Poison Centers.
Table 1 Summary of laboratory findings and treatment in three patients with metformin-associated/-induced lactic acidosis with hyperammonemia.
Table 1 Daily INR, warfarin concentrations and phytomenadione doses in a patient following massive warfarin overdose.
Table 1 Laboratory and diagnostic data in a patient with NMS after haloperidol.
Table 1 Patient characteristics, management, and outcome in 113 patients with 133 ICU admissions after chlordiazepoxide for alcohol withdrawal treatment.
Table 1 Methods of time correlation assessment between prescribing rates and intoxication events
Table 1 Demographics, other treatments and outcomes of dihydropyridine (DHP) calcium channel blocker (CCB) poisonings with shock [medians (IQR) or n (%)].
Table 1 Serial chemistry studies at hour (h) relative to time (T) of completion of deferoxamine bolus given over 1 h instead of 12 h.
Table 1 Call characteristics of Dutch and UK Poisons Information Centers in 2022.
Table 1 Results of a survey of hospital physicians and pharmacists on risk perceptions of nicotine and nicotine products (279 respondents).
Table 1 Vitamin enquiries to the National Poisons Information Centre in Ireland over a 5-year period (2018–2022).
Table 1 Blood cobalt concentration, 24-h urine cobalt excretion and acetylcysteine regimen with a metal-on-metal (MoM) hip prosthesis.
Table 1 Time to acetylcysteine, hepatotoxicity and outcome in patients with paracetamol overdose.
Table 1 Characteristics of patients with SGLT-2 inhibitor-associated euglycemic ketoacidosis.
Table 1 Buprenorphine dosing in a patient with severe COPD and opioid use disorder (OUD).
Table 1 Metal concentrations in biological samples and joint debris in a patient with a cobalt-chromium (CoCr) hip prosthesis.
Table 1 Occupational accidents involving plants and animals, 2012–2022.
Table 1 Epidemiology of deliberate self-poisonings (DSPs) reported to four European Poison Information Centers, 2017–2022.
Table 1 Substances involved in deliberate self-poisoning (DSP) reported to Poison Information Centers (PICs) from 2017 to 2022.
Table 1 Common substances in suicide exposures in adolescents comparing data from a US poison center (Rocky Mountain Poison and Drug Center) and an Italian poison center (Milan).